These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6722179)

  • 61. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
    Mosesson MW; Hernandez I; Siebenlist KR
    Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lipopolysaccharide-instructed, cryopreserved, human monocytes sequentially convert plasma fibrinogen to fibrin and lyse the fibrin formed.
    Kierulf P; Andersen AB
    Pathobiology; 1991; 59(3):197-9. PubMed ID: 1883514
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The isolation of fibrinogen monomer dramatically influences fibrin polymerization.
    Huang L; Lord ST
    Thromb Res; 2013 Jun; 131(6):e258-63. PubMed ID: 23622556
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The binding of calcium to fibrinogen: influence on the clotting process.
    Marguerie G; Benabid Y; Suscillon M
    Biochim Biophys Acta; 1979 Jul; 579(1):134-41. PubMed ID: 465525
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implications.
    Galanakis DK
    Semin Thromb Hemost; 1992 Jan; 18(1):44-52. PubMed ID: 1574716
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Simulating fibrin clotting time.
    Marx G
    Med Biol Eng Comput; 2006 Mar; 44(1-2):79-85. PubMed ID: 16929924
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The influence of fibrinogen degradation products on the reptilase-time of plasma.
    Arnesen H; Kierulf P; Godal HC
    Scand J Haematol; 1973; 11(5):360-6. PubMed ID: 4798341
    [No Abstract]   [Full Text] [Related]  

  • 69. Thrombin activity of fibrin thrombi and soluble plasmic derivatives.
    Francis CW; Markham RE; Barlow GH; Florack TM; Dobrzynski DM; Marder VJ
    J Lab Clin Med; 1983 Aug; 102(2):220-30. PubMed ID: 6223106
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interaction of hementin with fibrinogen and fibrin.
    Budzynski AZ
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):149-52. PubMed ID: 1772982
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assembly.
    Dang CV; Shin CK; Bell WR; Nagaswami C; Weisel JW
    J Biol Chem; 1989 Sep; 264(25):15104-8. PubMed ID: 2549051
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Detection of thrombin-induced fibrinogen derivatives in thrombotic states.
    Heene DL; Matthias FR
    Bibl Haematol; 1977; 44():161-8. PubMed ID: 617780
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fibrin assembly in human plasma and fibrinogen/albumin mixtures.
    Torbet J
    Biochemistry; 1986 Sep; 25(18):5309-14. PubMed ID: 3768349
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amino acids and peptides XII: synthetic peptides related to the N-terminal portion of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting.
    Kawasaki K; Hirase K; Tsuji T; Miyano M; Iwamoto M
    Thromb Res; 1989 Dec; 56(6):757-62. PubMed ID: 2633403
    [No Abstract]   [Full Text] [Related]  

  • 76. Fibrinogen-fibrin transformations characterized during the course of reaction by their intermediate structures. A light scattering study in dilute solution under physiological conditions.
    Mueller M; Burchard W
    Biochim Biophys Acta; 1978 Dec; 537(2):208-25. PubMed ID: 728446
    [TBL] [Abstract][Full Text] [Related]  

  • 77. THE BINDING OF HUMAN FIBRINOGEN TO NATIVE AND FRACTION FIBRINS AND THE INHIBITION OF POLYMERIZATION OF A NEW HUMAN FIBRIN MONOMER BY FIBRINOGEN.
    COPLEY AL; LUCHINI BW
    Life Sci (1962); 1964 Nov; 3():1293-305. PubMed ID: 14231779
    [No Abstract]   [Full Text] [Related]  

  • 78. Delayed fibrin polymerization due to removal of calcium ions.
    Godal HC
    Scand J Clin Lab Invest; 1969 Aug; 24(1):29-33. PubMed ID: 4986919
    [No Abstract]   [Full Text] [Related]  

  • 79. Shear dependence of the fibrin coagulation kinetics in vitro.
    Tippe A; Müller-Mohnssen H
    Thromb Res; 1993 Dec; 72(5):379-88. PubMed ID: 8303681
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Soluble fibrin consists of fibrin oligomers of heterogeneous distribution.
    Rötker J; Preissner KT; Müller-Berghaus G
    Eur J Biochem; 1986 Mar; 155(3):583-8. PubMed ID: 3956500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.